Study: Reolysin-Paclitaxel Combination Demonstrates Higher Response than Paclitaxel Therapy Alone March 31, 2016Vol.39 No.03
Atezolizumab Immunotherapy Boosts OS Compared to Docetaxel in Phase II Trial March 31, 2016Vol.39 No.03
Vyxeos Injection Improves Overall Survival in Phase III Acute Myeloid Leukemia Trial March 31, 2016Vol.39 No.03
Free NEJM Editors: There Will Be No Clarification For Disputed Power Morcellation Story March 25, 2016Vol.42 No.12By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Clifford Hudis Named CEO of ASCO March 25, 2016Vol.42 No.12By Paul Goldberg
Bunn Wins ASCO Karnofsky Award; Kaelin to Receive Science of Oncology Award March 18, 2016Vol.42 No.11
